Clinical Relevance of High Plasma Trough Levels of the Kinase Inhibitors Crizotinib, Alectinib, Osimertinib, Dabrafenib, and Trametinib in NSCLC Patients
Lin, Lishi, Barkman, Hannerieke J, Smit, Egbert F, de Langen, Adrianus J, Steeghs, Neeltje, Beijnen, Jos H, Huitema, Alwin D R
Published in Therapeutic drug monitoring (01.02.2024)
Published in Therapeutic drug monitoring (01.02.2024)
Get more information
Journal Article
A cost analysis study of the implementation of fixed-dosing of monoclonal antibodies in the Netherlands Cancer Institute
Heinhuis, Kimberley M., Barkman, Hannerieke J., Beijnen, Jos H., Hendrikx, Jeroen J. M. A.
Published in International journal of clinical pharmacy (01.02.2021)
Published in International journal of clinical pharmacy (01.02.2021)
Get full text
Journal Article
Redispensing of expensive oral anticancer medicines: A practical application
Akgöl, Kübra, van Merendonk, Lisanne N, Barkman, Hannerieke J, van Balen, Dorieke Em, van den Hoek, Hester L, Klous, Marjolein G, Hendrikx, Jeroen Jma, Huitema, Alwin Dr, Beijnen, Jos H, Nuijen, Bastiaan
Published in Journal of oncology pharmacy practice (01.04.2024)
Published in Journal of oncology pharmacy practice (01.04.2024)
Get more information
Journal Article